QVAR 80 (beclomethasone dipropionate) Teva branded pharm Patent: 6,446,627 Expiration: Dec 18, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug Patent …
Drug Patent Expirations for the Week of December 17, 2017 Read Post »
Annual Drug Patent Expirations for QVAR+REDIHALER Qvar Redihaler is a drug marketed by Norton Waterford and is included in one NDA. There are four patents protecting this drug. This drug…
The post New patent expiration for Norton Waterford drug Q…
New patent expiration for Norton Waterford drug QVAR REDIHALER Read Post »
Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Teva Branded drug PROAIR RESPI…
New patent expiration for Teva Branded drug PROAIR RESPICLICK Read Post »
QVAR 80 (beclomethasone dipropionate) Teva branded pharm Patent: 6,446,627 Expiration: Dec 18, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug Patent …
Drug Patent Expirations for the Week of December 17, 2017 Read Post »
Annual Drug Patent Expirations for OXANDRIN Oxandrin is a drug marketed by Gemini Labs Llc and is included in one NDA. There are four patents protecting this drug and one…
The post New patent expiration for Gemini Labs drug OXANDRIN appeared firs…
New patent expiration for Gemini Labs drug OXANDRIN Read Post »
Annual Drug Patent Expirations for FAZACLO+ODT Fazaclo Odt is a drug marketed by Jazz Pharms Iii and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Jazz Pharms drug FAZACLO ODT appeared f…
New patent expiration for Jazz Pharms drug FAZACLO ODT Read Post »
Annual Drug Patent Expirations for RYBIX+ODT Rybix Odt is a drug marketed by Shionogi Inc and is included in one NDA. There is one patent protecting this drug. This drug…
The post New patent expiration for Shionogi Inc drug RYBIX ODT appeared fir…
New patent expiration for Shionogi Inc drug RYBIX ODT Read Post »
CIALIS (tadalafil) Lilly Patent: 5,859,006 Expiration: Nov 21, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post D…
Drug Patent Expirations for the Week of November 19, 2017 Read Post »
Annual Drug Patent Expirations for INOMAX Inomax is a drug marketed by Mallinckrodt Hosp and is included in one NDA. It is available from one supplier. There are seventeen patents…
The post New patent expiration for Mallinckrodt Hosp drug INOMAX …
New patent expiration for Mallinckrodt Hosp drug INOMAX Read Post »
Annual Drug Patent Expirations for INVANZ Invanz is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There is one…
The post New patent expiration for Merck Sharp drug INVANZ appeared first on Dru…
New patent expiration for Merck Sharp drug INVANZ Read Post »